Blood biomarkers for Alzheimer’s disease in clinical practice and trialsOskar Hansson, Jeffrey L. Dage|Nature Aging|2023Cited by 443
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s diseaseMarta Milà‐Alomà, Kaj Blennow, Juan Lantero‐Rodriguez et al.|Nature Medicine|2022Cited by 349
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Chengran Yang, Rowan Saloner et al.|Nature Medicine|2025Cited by 85
Novel avenues of tau researchClaire E. Sexton, María C. Carrillo, Gal Bitan et al.|Alzheimer s & Dementia|2024Cited by 17